Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 256

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials

Dumont, Larry J., AuBuchon, James P., Biomedical Excellence for Safer Transfusion (BEST) Collaborative·2008·Transfusion

Abstract

BACKGROUND: FDA requirements for recovery of radiolabeled red blood cells (RBCs) 24 hours after autologous reinfusion in normal subjects have evolved over time. This study defined the ability of currently available RBC systems to satisfy the most recently proposed criteria. STUDY DESIGN METHODS: RBC recoveries were collected from US laboratories participating in clinical trials for RBC systems that have received FDA approval. Data were stratified for analysis into liquid‐stored, gamma‐irradiated, and frozen components. With statistical software, 24 individual samples were randomly selected with replacement from each stratum, repeating this for 5000 sample groups per stratum, to simulate experimental outcomes for each population. The percentage of sample groups that passed each and all of the proposed FDA criteria was determined. This procedure was repeated for recovery success thresholds of 75, 70, and 67 percent. RESULTS: A total of 941 RBC recoveries were obtained from 11 laboratories and 34 studies performed between 1990 and 2006 for 12 sponsors. While the criterion for the mean was almost always satisfied, the standard deviation (SD) criterion was more problematic. Causing most failures was the success threshold definition. Changing the success threshold from 75 to 70 percent or 67 percent increased the likelihood of meeting the requirement for all RBC types. CONCLUSION: The probability of passing the FDA‐proposed criteria for currently FDA‐approved products was poor. Changing the success threshold for an individual RBC recovery from 75 to 67 percent resulted in improved ability to meet this criterion for all three RBC types. This change had no affect on the pass rates based on the mean and SD criteria.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1537-2995.2008.01642.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 256

Metadata

Authors
Dumont, L. J., AuBuchon, J. P., & Collaborative, B. E. F. S. T. (.
Venue
Transfusion
Publisher
Wiley
Published
2008-02-22
Volume
48
Issue
6
Pages
1053-1060
ISSN
  • 0041-1132 (ISSN-L)
  • 1537-2995
OpenAlex
W2013291317
Cited by
256
References
3
FWCI
3.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. https://app.cochat.ai/papers/10.1111/j.1537-2995.2008.01642.x
The paper
Dumont, L. J., AuBuchon, J. P., & Collaborative, B. E. F. S. T. (. (2008). Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion. https://doi.org/10.1111/j.1537-2995.2008.01642.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.